Intellia (NTLA) Q4 2025 Earnings Call Transcript
Source: Motley Fool
2026-02-26 14:45:39 ET
Image source: The Motley Fool.
Thursday, Feb. 26, 2026 at 8 a.m. ET
Need a quote from a Motley Fool analyst? Email pr@fool.com
Intellia Therapeutics Inc.
NASDAQ: NTLA
NTLA Trading
0.03% G/L:
$12.73 Last:
1,289,650 Volume:
$13.02 Open:
NTLA Latest News
March 03, 2026 07:30:00 am
Intellia Therapeutics Presents Longer-Term Clinical Data for Lonvoguran Ziclumeran (lonvo-z); Hereditary Angioedema (HAE) Patient-Focused Research at AAAAI 2026
March 02, 2026 07:30:00 am
Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE Phase 3 Clinical Trial in ATTR-CM
NTLA Stock Data
$1,420,074,893
112,239,198
1.45%
105
N/A
Biotechnology & Life Sciences
Healthcare
US
Cambridge
